Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA) (CeMoD-prime)

A Randomized Controlled Trial Comparing Modular Dual Mobility Inserts With Ceramic Multilayer Coating Versus Standard Polyethylene Inserts for Primary Total Hip Arthroplasty (THA) in a Cementless Acetabular Cup

A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup

Study Overview

• Status: Recruiting
• Conditions: Coxarthrosis; Primary
• Intervention / Treatment: Device: Dual Mobility Cup; Device: Standard Acetabular component

Detailed Description

The aim of this study is to show in a randomized controlled trial that cobalt and chromium ion serum levels are comparable to the metal ion levels in patients with standard articulation with metal head. The metal on polyethylene articulation is accepted as standard articulation since many decades, and which is currently in the Czech Republic the most used combination. Most studies which focused on the topic of metal ion release from modular dual mobility systems do not present results of a control group with standard articulation hip implants.

• Study Type: Interventional
• Enrollment (Estimated): 100
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Stefan Maenz, Dr.; Phone Number: +49746195; Email: info@aesculap.de

Study Locations

• Czechia
  • Ústí nad Labem, Czechia
    • Recruiting
    • Masaryk Hospital
    • Contact: Tomas Novotny, MuDr.

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Primary coxarthrosis patients indicated for cementless total hip arthroplasty
• Written informed patient consent

Exclusion Criteria:

• Hip trauma or revision surgery
• Rheumatoid or neurologic disease
• BMI >35
• Ongoing oncologic therapy
• Preoperatively elevated Co or Cr serum levels >1.0 µg/L
• Patients with other joint implants, or anticipated need for another joint replacement surgery within the study period
• Acetabular cup size <52 expected
• Patients not able to mentally or physically comply with the study demands and follow-up visits
• Patients <18 years at surgery
• Pregnancy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Dual Mobility Cup; dual mobility articulation	Device: Dual Mobility Cup; Total hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the Dual Mobility cup; Other Names: Total Hip Arthroplasty
Active Comparator: Standard Acetabular component; standard articulation with polyethylene + vitamin E inlay and metal head	Device: Standard Acetabular component; Total hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the standard device with polyethylene + vitamin E inlay and metal head; Other Names: Total Hip Arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Serum metal ion analysis (Cobalt)	Cobalt ion levels in blood serum in measured in [µg/L], Comparison between the two groups	12 months after surgery
Serum metal ion analysis (Chromium)	Chromium ion levels in blood serum in measured in [µg/L], Comparison between the two groups	12 months after surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change of functional outcome over three year follow-up period (Harris Hip Score)	The Harris Hip Score (HHS) is one of the most used scores in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100, any result <70 is considered a poor result; The HHS is an outcome measure administered by a qualified health care professional, such as a physician or a physical therapist.	3 months, 12 months and 3 years postoperatively
Gait analysis over time	The gait lab analysis involves a high amount of recorded data and variables. Gait lab analyses are performed with the patients between the preoperative state, 3 months after surgery and 1 year postoperative. The Gait Profile Score (GPS) is used as a measure for the deviation in gait kinematics from a healthy patient population to compare the two treatment groups. Lower score values can be considered as a sign of better restoration of the physiological gait kinematics.	preoperative, 3 months and 12 months postoperatively
Development of Patient satisfaction with surgery result over time	Patient is asked for satisfaction with surgery result with a 4-point scale: very satisfied, satisfied, unsatisfied, very unsatisfied	at three examinations during Follow-Up (3 months postop, 1 year postop, 3 years postop)
Radiologic Evaluation: Cup Inclination over time	Inclination is the orientation of the cup in the coronal plane. The target acetabular cup inclination is a "safe zone" between 30-50° abduction (assessed on antero-posterior (ap) x-rays of the hip). The comparison of the intraoperatively achieved inclination and the inclination at different follow-up examinations allows prediction on longterm success.	immediately postoperative, 3 months, 12 months and 3 years postoperative
Radiologic Evaluation: center of rotation	Centre of Rotation (CoR) is defined as the zero position for the measurement of potential cup migration. Horizontal: Distance of CoR to ipsilateral teardrop; Vertical: Distance CoR to Inter-teardrop line; The comparison of the intraoperatively center of rotation and the center of rotation at different follow-up examinations allows prediction on longterm success.	immediately postoperative, 3 months, 12 months and 3 years postoperative
Radiologic Evaluation: Radiolucencies around the cup	Bony Osseointegration or conspicuous features of the cup are assessed on anterior-posterior and lateral x-rays of the cup and will be analysed according to the zones defined by Charnley. "Charnley" zones of the acetabular component are distinct zones used in assessment of aseptic loosening in total hip joint replacements. The radiolucencies are categorized to "none", "less than or equal to 2mm" and "more than 2 mm"	over follow-up period 3 months, 12 months and 3 years postoperative
Radiological Outcome: Heterotopic Ossification	Brooker classification divides heterotopic ossifications that form following total hip replacement to four classes. Class I: islands of bone within soft tissues around hip; Class II: bone spurs in pelvis or proximal end of femur leaving ≥1 cm between the opposing bone surfaces; Class III: bone spurs that extend from pelvis or the proximal end of femur, which reduce the space between the opposing bone surfaces to <1cm; Class IV: ankylosis of the hip on x-ray	over follow-up period 3 months, 12 months and 3 years postoperative

Collaborators and Investigators

• Sponsor: Aesculap AG

Study record dates

Study Major Dates

• Study Start (Actual): November 21, 2022
• Primary Completion (Estimated): September 1, 2025
• Study Completion (Estimated): September 1, 2027

Study Registration Dates

• First Submitted: September 16, 2022
• First Submitted That Met QC Criteria: September 16, 2022
• First Posted (Actual): September 21, 2022

Study Record Updates

• Last Update Posted (Estimated): February 21, 2024
• Last Update Submitted That Met QC Criteria: February 20, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Keywords: Total Hip Arthroplasty; Dual Mobility Cup
• Additional Relevant MeSH Terms: Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Arthritis; Osteoarthritis; Osteoarthritis, Hip
• Other Study ID Numbers: AAG-G-H-2203

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No